Dorababu Atukuri (Atukuri Dorababu, Atukuri Dorbabu)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Pulmonary Fibrosis

Molecular Docking

Structure Activity Relationship

Top Venues

Archiv der Pharmazie

RSC medicinal chemistry

Molecules (Basel, Switzerland)

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Dorababu Atukuri
Role of heterocycles in inhibition of VEGFR-2 - a recent update (2019-2022). RSC medicinal chemistry 15 (2) (2023)
Dorababu Atukuri
Role of heterocycles in inhibition of VEGFR-2 - a recent update (2019-2022). RSC medicinal chemistry 15 (2) (2023)
Dorababu Atukuri, Manikantha Maraswami
Recent Advances (2015-2020) in Drug Discovery for Attenuation of Pulmonary Fibrosis and COPD. Molecules (Basel, Switzerland) 28 (9) (2023)
Dorababu Atukuri, Manikantha Maraswami
Recent Advances (2015-2020) in Drug Discovery for Attenuation of Pulmonary Fibrosis and COPD. Molecules (Basel, Switzerland) 28 (9) (2023)
Dorababu Atukuri
Pyrazole/pyrazoline as an excellent pharmacophore in the design of carbonic anhydrase inhibitors (2018-2022). Archiv der Pharmazie (2023)
Dorababu Atukuri
Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update. Archiv der Pharmazie 355 (10) (2022)
Dorababu Atukuri
Pharmacological report of recently designed multifunctional coumarin and coumarin-heterocycle derivatives. Archiv der Pharmazie (2021)
Dorababu Atukuri, Rutu Gunjal, Nagaraj Holagundi, Bibiashabi Korlahalli, Sanjeevini Gangannavar, Kirankumar Akkasali
Contribution of N-heterocycles towards anti-tubercular drug discovery (2014-2019); predicted and reengineered molecular frameworks. Drug development research 82 (6) (2021)
Dorababu Atukuri
Recent update on antibacterial and antifungal activity of quinoline scaffolds. Archiv der Pharmazie 354 (3) (2020)
Dorababu Atukuri
Indole - a promising pharmacophore in recent antiviral drug discovery. RSC medicinal chemistry 11 (12) (2020)